| Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept B Altieri, G Muscogiuri, L Barrea, C Mathieu, CV Vallone, L Mascitelli, ... Reviews in Endocrine and Metabolic Disorders 18, 335-346, 2017 | 195 | 2017 |
| Vitamin D and chronic diseases: the current state of the art G Muscogiuri, B Altieri, C Annweiler, G Balercia, HB Pal, BJ Boucher, ... Archives of toxicology 91, 97-107, 2017 | 192 | 2017 |
| Shedding new light on female fertility: The role of vitamin D G Muscogiuri, B Altieri, C de Angelis, S Palomba, R Pivonello, A Colao, ... Reviews in Endocrine and Metabolic Disorders 18, 273-283, 2017 | 166 | 2017 |
| Vitamin D testing: advantages and limits of the current assays B Altieri, E Cavalier, HP Bhattoa, FR Perez-Lopez, MT Lopez-Baena, ... European journal of clinical nutrition 74 (2), 231-247, 2020 | 111 | 2020 |
| Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer B Altieri, WB Grant, S Della Casa, F Orio, A Pontecorvi, A Colao, G Sarno, ... Critical reviews in food science and nutrition 57 (16), 3472-3488, 2017 | 103 | 2017 |
| Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication J Lippert, S Appenzeller, R Liang, S Sbiera, S Kircher, B Altieri, I Nanda, ... The Journal of Clinical Endocrinology & Metabolism 103 (12), 4511-4523, 2018 | 98 | 2018 |
| Gemcitabine-based chemotherapy in adrenocortical carcinoma: a multicenter study of efficacy and predictive factors JEK Henning, T Deutschbein, B Altieri, S Steinhauer, S Kircher, S Sbiera, ... The Journal of Clinical Endocrinology & Metabolism 102 (11), 4323-4332, 2017 | 95 | 2017 |
| Next-generation therapies for adrenocortical carcinoma B Altieri, CL Ronchi, M Kroiss, M Fassnacht Best Practice & Research Clinical Endocrinology & Metabolism 34 (3), 101434, 2020 | 76 | 2020 |
| Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma LS Landwehr, B Altieri, J Schreiner, I Sbiera, I Weigand, M Kroiss, ... Journal for ImmunoTherapy of Cancer 8 (1), 2020 | 75 | 2020 |
| Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study T Deutschbein, G Reimondo, G Di Dalmazi, I Bancos, J Patrova, ... The Lancet Diabetes & Endocrinology 10 (7), 499-508, 2022 | 65 | 2022 |
| S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study YS Elhassan, B Altieri, S Berhane, D Cosentini, A Calabrese, ... European Journal of Endocrinology 186 (1), 25-36, 2022 | 58 | 2022 |
| Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness L Barrea, B Altieri, G Muscogiuri, D Laudisio, G Annunziata, A Colao, ... Nutrients 10 (12), 1854, 2018 | 56 | 2018 |
| CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma CL Ronchi, S Sbiera, M Volante, S Steinhauer, V Scott-Wild, B Altieri, ... PloS one 9 (8), e105855, 2014 | 54 | 2014 |
| Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors< 2 centimeters A Faggiano, R Modica, F Lo Calzo, L Camera, V Napolitano, B Altieri, ... The Journal of Clinical Endocrinology & Metabolism 105 (1), 78-84, 2020 | 46 | 2020 |
| Focus on vitamin D and the adrenal gland G Muscogiuri, B Altieri, M Penna-Martinez, K Badenhoop Hormone and Metabolic Research 47 (04), 239-246, 2015 | 45 | 2015 |
| Nutrition and neuroendocrine tumors: An update of the literature B Altieri, L Barrea, R Modica, G Muscogiuri, S Savastano, A Colao, ... Reviews in Endocrine and Metabolic Disorders 19, 159-167, 2018 | 42 | 2018 |
| Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective G Muscogiuri, B Altieri, M Albertelli, A Dotto, R Modica, L Barrea, ... Endocrine 69, 441-450, 2020 | 40 | 2020 |
| Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements L Barrea, B Altieri, B Polese, B De Conno, G Muscogiuri, A Colao, ... International Journal of Obesity Supplements 9 (1), 32-49, 2019 | 39 | 2019 |
| Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma S Puglisi, A Calabrese, V Basile, F Ceccato, C Scaroni, B Altieri, ... Cancers 12 (3), 740, 2020 | 38 | 2020 |
| Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study G Muscogiuri, L Barrea, C Di Somma, B Altieri, M Vecchiarini, F Orio, ... Hormones 18 (1), 75-84, 2019 | 38 | 2019 |
